Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

CUSIP: 15673T100

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,670,044
Total 13F shares
22,151,698
Share change
+1,012,464
Total reported value
$278,859,136
Price per share
$12.59
Number of holders
51
Value change
+$11,504,710
Number of buys
28
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 15673T100?
CUSIP 15673T100 identifies IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q1 2022

As of 31 Mar 2022, Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,151,698 shares. The largest 10 holders included FMR LLC, Casdin Capital, LLC, FEDERATED HERMES, INC., BlackRock Inc., Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Avidity Partners Management LP, VANGUARD GROUP INC, MARSHALL WACE, LLP, and Octagon Capital Advisors LP. This page lists 51 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.